To determine important risk factors associated with cases of gonorrhoea in England, and whether any particular risk groups were associated with the substantial rise in numbers of cases seen between 1994 and 1996. Design: Two retrospective cross sectional surveys. Setting: 70 randomly selected genitourinary medicine (GUM) clinics in England.
Introduction
Between 1995 and 1996, there was a 20% rise in the number of cases of gonorrhoea seen in genitourinary medicine (GUM) clinics in England. 1 This followed a smaller increase between 1994 and 1995 1 and the trend has continued into 1997. 2 The rise between 1995 and 1996 was the largest proportional annual increase in diagnoses since 1945 (Communicable Disease Surveillance Centre (CDSC), unpublished data). It took place in almost every health region, occurred in heterosexuals as well as in homo/bisexual men, and was greatest in men and women aged 16-19 years. Gonorrhoea rates are thought to be a reasonable indicator of changes in sexual behaviour. 3 The dramatic and substantial decline in numbers of people attending medicine GUM with gonorrhoea during the 1980s 4 may have resulted from changes in sexual behaviour in homosexual men 3 5 6 as well as heterosexuals 5 associated with the increased media coverage of AIDS. Gonorrhoea is the only sexually transmitted infection for which a target was set in the Health of the Nation 7 as it was thought to be a convenient marker of behaviour likely to influence HIV transmission. 7 Consequently, the resurgence of gonorrhoea diagnoses during the 1990s is of considerable public health concern.
In looking for possible factors behind the recent rise it is noteworthy that higher rates of gonorrhoea among black groups than among the general white population have recently been highlighted in two urban areas. 8 9 However, as routine statistics from GUM clinics give limited risk factor information, 10 it was not possible to determine whether black groups are at higher risk throughout England or if they contributed disproportionately to the latest increase.
This investigation had two aims. Firstly, we wished to determine important risk factors for gonorrhoea at the national level. Secondly, we examined whether the recent rise in numbers of gonorrhoea diagnoses was associated with changes in risk behaviours or with any particular risk group.
Subjects and methods

STUDY DESIGN AND SAMPLE SIZE
The investigation was in two parts: (1) an analysis of risk factors for gonorrhoea patients in 1996 (study 1), and (2) a comparison of risk factors for gonorrhoea in 1996 with those in 1994 to determine whether there had been a significant change in risk factors between these years (study 2). Two cross sectional surveys of gonorrhoea patients attending GUM clinics in 1994 and 1996 were carried out. A total sample size of about 2000-that is, approximately 10% of all patients with gonorrhoea seen in GUM clinics in England in 1994 and 1996, was required in order to detect an odds ratio (OR) of 1.5 or more when 10% or more of patients in 1994 belonged to a risk group (5% significance, 80% power). A necessity to analyse by sexual orientation meant that detectable ORs were 2.4 or more for homo/bisexual men and 1.7 or more for heterosexuals.
SAMPLING STRATEGY
Clinics
Two thirds of genitourinary medicine (GUM) clinics in inner London and a third of GUM clinics in the rest of England were randomly selected from each of nine size categories, determined by the number of gonorrhoea cases they reported in 1996 (0-5, 6-10, 11-20, 21-30, 31-50, 51-100, 101-200, 201-520, or 521-1000). Inner London clinics were deliberately oversampled so that there were suYcient numbers for subgroup analyses of homosexual men. Nine of the 75 selected clinics (12%) were unable to participate and were each replaced with another from the same size class. Four clinics reported no gonorrhoea cases and one was subsequently unable to participate, leaving 70 participating clinics.
Subjects
Listings of all patients attending with uncomplicated gonorrhoea (KC60 code B1B2) at each selected clinic in 1994 and 1996 were generated. One of the first four patients was randomly selected and, thereafter, every fourth patient. Repeat attenders were included. The following information was obtained from the patients' notes and recorded on a standard proforma: Clinic, patient number, date of attendance, sex, date of birth, site of infection, drug sensitivity (only qualitative data on drug sensitivity were collected-that is, we did not collect information on laboratory methodology and minimum inhibitory concentrations), drug given for treatment of gonorrhoea, ethnic group, country of birth, sexual orientation, marital status, number of partners in the past 3 months, sex abroad in the past 3 months, concurrent diagnoses, and date and diagnosis of any previous attendance at a GUM clinic. DATA ANALYSIS Unless otherwise specified, the data and analyses presented here include adjustments for the oversampling of patients from inner London clinics. Data from inner London clinics were downweighted by 50%. As there were no more than six repeat attenders included in the data set, both within and between the 2 years, it was not deemed necessary to account for duplicates in the analyses. To determine whether the study patients were representative of all cases of gonorrhoea seen in GUM clinics, study cases from 1996 were compared by sex, age group, sexual orientation, and regional distribution to all gonorrhoea cases seen in GUM clinics in England in 1996 (KC60 data) 1 using 2 tests.
Study 1: Risk factors for cases in 1996
Numbers of patients from inner London clinics were halved to account for oversampling. Incidence rates per 100 000 population aged 14-70 and relative rates were calculated for selected patient characteristics in 1996 with denominators derived from 1996 mid-year population estimates 11 (region, sex, and age estimates), the 1991 census 12 adjusted for undercoverage by age, sex, and ethnic group 13 (ethnic group and area of birth estimates) and the National Study of Sexual Attitudes and Lifestyles 14 (sexual orientation and previous GUM clinic attendance estimates). To estimate incidence rates, the number of patients in 1996 was first multiplied by 12 (as after the London clinics were downweighted by 50% one twelfth of patients had been sampled). Relative rates (RRs) in 1996 were calculated from [C(e)/ C(b)]/[P(e)/P(b)] where C(e) denotes the proportion of patients exposed, C(b) the proportion of patients with the baseline characteristic, P(e) the proportion of the population exposed, and P(b) the proportion of the population with the baseline characteristic.
Confidence intervals were calculated as for relative risks (equivalent in this case). Cases for which ethnicity was not recorded were assumed to be white and those for which country of birth was not recorded were assumed to have been born in the United Kingdom.
Study 2: Change in risk factors between 1994 and 1996
The odds ratios among those with the disease were compared directly between 1994 and 1996 using logistic regression with being a case in 1996 (as opposed to 1994) as the outcome variable. If a factor is not associated with the outcome variable then the increase in cases observed between 1994 and 1996 is similar in the groups defined by the factor. It was not possible to calculate odds ratios for many sexual behaviour and clinical characteristics for 1994 and 1996 directly, as data on the frequency of these characteristics in the general population are not available. For this method it was assumed that the proportion of the population belonging to a given risk group changed little between 1994 and 1996.
Univariable and multivariable analyses were carried out using STATA software. 15 Data for patients from inner London clinics were given a sampling weighting of 6, and those from remaining clinics a weighting of 12, since the probabilities of patients from these areas being included in the sample were 1/6 and 1/12, respectively (using the [pweight=] command in stata 15 ). All patient and infection characteristics collected on the proforma were compared between cases in 1994 and 1996 using univariable analyses. Only those factors which were significant at p<0.2 in the univariable analyses (sex, sex abroad, previous GUM clinic attendance, concurrent acute sexually transmitted infection (STI), site, sensitivity to penicillin, treatment), and those which were of particular interest (region, age, ethnic group, number of partners, previous acute STI), were included as explanatory variables in the multivariable models. Separate models were run for heterosexuals and for homo/bisexual men because the distribution of many demographic and behavioural characteristics varied considerably between these groups. In the heterosexual model, interactions between sex and each of the explanatory variables were investigated. As there were strong regional diVerences in the recording of ethnic group in patients' case notes, interactions between region and the presence or absence of ethnic group data were investigated in both models.
Results
Data were collected on 847 patients in 1994 and 1146 patients in 1996, giving an unadjusted total of 1993 patients overall. Just over half of these patients were seen in inner London clinics.
The study patients in 1996 were not significantly diVerent from all cases reported in the 1996 KC60 data set by sex ( 2 = 1.2; df = 1; p = 0.27) or age ( 2 = 4.1; df=3; p = 0.25). However, 30% of males in the study in 1996 were homosexual or bisexual, significantly more than the 21% reported nationally ( 2 = 24.4; df = 1; p <0.001). The regional distribution also diVered significantly between the two data sets ( 2 = 91.9; df = 7; p <0.001). Patients from the North West and West Midlands accounted for higher and lower proportions, respectively, of patients in the study than all cases. The distributions of patients in 1996 (adjusted for London oversampling) are presented by region, sex, age group, sexual orientation, ethnic group, area of birth, and previous GUM clinic attendance in table 1.
White people were the largest ethnic group nationally and in all regions except South Thames. Northern and Yorkshire was the only region with no black Caribbean patients recorded and, in the remaining regions, the proportion of patients who were black Caribbean ranged from 4% in the North West to 62% in South Thames. Overall, ethnic group was not recorded for 30% of patients although this ranged from 6% in Trent to 67% in the North West. Ethnic group was not recorded for 10% of patients in South Thames, for 13% in North Thames, and for 20% in the West Midlands. Seventy four per cent of white people and 96% of black Caribbeans were heterosexual.
Twenty nine per cent of patients in 1996 had a concurrent acute sexually transmitted infections (STI) (see box) and 22% had previously had an acute STI. Eight per cent had a penicillin resistant gonococcal strain (that is, all penicillinase producing Neisseria gonorrhoeae (PPNG) and chromosomally mediated penicillin resistant N gonorrhoeae (CMRNG)) whereas less than 1% were resistant to quinolones or to tetracycline. Penicillin resistance was more common in homo/bisexual men, with 18% of patients resistant, compared with women and heterosexual men, with 4% and 7% resistant, respectively.
Site of infection was recorded for 98% of patients in 1996. Ninety per cent of females, over 99% of heterosexual males, and 67% of homo/bisexual men had genital gonorrhoea. Rectal gonorrhoea was found in 24% of homo/ bisexual men and 10% of females, but not in heterosexual males. Throat infections were found in 9% of homo/bisexual men but in less than 1% of heterosexual men and women.
Number of partners in the past 3 months, and sex abroad in the past 3 months, was recorded for 98% and 92%, respectively, of patients in 1996. Twenty nine per cent of heterosexual females, 54% of heterosexual males, and 59% of homo/bisexual males reported two or more partners during this period. Five per cent of patients reported sex abroad.
Incidence and relative rates for selected characteristics of patients in 1996 are shown in table 1. Incidence was particularly high for homo/ bisexual males compared with heterosexual males, black Caribbean and black African cases relative to white cases, and for those who had previously attended a GUM clinic. Descriptive analyses Between 1994 and 1996, diagnoses in females rose by 25% (215 to 268), in heterosexual males by 46% (263 to 385), and in homo/ bisexual males by 31% (126 to 166). In females, the largest increase was in 16-19 year olds and percentage increases diminished with age ( fig 1A) . In heterosexual males large rises occurred across most age groups ( fig 1B) while in homo/bisexual males, the largest proportional increases were in the over 35s ( fig 1C) .
Multivariable analyses
Adjusted risk factors for being a gonorrhoea patient in 1996 compared to being a patient in 1994 are presented in table 2.
For heterosexuals, patients in 1996 were significantly more likely to be males, to have had no or one sexual partners in the past 3 months compared with two, and to have reduced sensitivity to penicillin than cases in 1994. There were no interactions between sex and any of the explanatory variables in the model.
For homo/bisexual men, patients in 1996 were significantly more likely to be from the North West and to have either reduced sensitivity or complete resistance to penicillin than cases in 1994.
There was evidence for an interaction between region and the presence or absence of ethnic data ( 2 =13.7, df=7, p=0.057 for the heterosexual model; 2 =14.6, df=3, p=0.002 for the male homo/bisexual model). Clinics in the Thames regions improved the recording of ethnic data between 1994 and 1996, whereas clinics in other regions did not.
Discussion
We report on the first national investigation of risk factors associated with cases of gonorrhoea, and of possible causes of the recent rise in numbers of diagnoses, in a study which sampled 10% of all gonorrhoea patients attending GUM clinics in England in 1994 and 1996. Overall, gonorrhoea patients selected for this study were found to be fairly representative of all gonorrhoea cases seen in GUM clinics in England. The oversampling of cases from the North West and of homo/bisexual men probably arose from the random sampling of particularly large clinics in the North West, and of clinics attended predominantly by homo/ bisexual men. Consequently, the incidence and relative rate of gonorrhoea in homo/bisexual men and in the North West region in 1996 are likely to be overestimated. The high rates of gonorrhoea in homo/bisexual men are of continuing concern. This study indicated that about a quarter of infections in homo/bisexual men were rectal, whereas infections of the throat only, indicative of safer sexual behaviour in terms of HIV transmission, 16 made up fewer than 10% of cases. Variations on policy on anatomical sites routinely screened for gonorrhoea may have led to an underestimate of the proportion of rectal and throat infections. Clearly, however, many homo/bisexual men attending GUM clinics with gonorrhoea have placed themselves at risk of HIV infection through unsafe sexual practice. In 1997, an estimated 9% of homo/ bisexual men attending GUM clinics in London, and 4% attending clinics elsewhere in England and Wales, were infected with HIV. 17 At the national level, incidence of gonorrhoea was far higher for black Caribbeans, who constituted at least 18% of all patients, than for white people. This is in accordance with results from localised studies. 8 9 None the less, the bulk of gonorrhoea patients were white heterosexuals.
Recording of ethnicity tended to be better in the Thames regions, which along with the West Midlands have much higher black ethnic minority populations. 12 To prevent overestimation of relative rates for gonorrhoea in ethnic minorities, cases for which ethnicity and/or country of birth data were not recorded were assumed to be white and/or born in the United Kingdom. This was reasonable since areas with the most missing data have relatively small black ethnic minority populations. The likely eVect of misclassification due to this assumption will have been to underestimate the size of relative rates associated with non-white ethnic groups. Variations in the methods of recording ethnicity (such as whether ethnicity is assigned by the patient or clinic reception staV) also place limitations on the robustness of ethnic groupings.
Despite these limitations, this study confirms that the black Caribbean population experiences a disproportionate burden of gonococcal infections. The reasons for the unequal distribution of gonorrhoea across ethnic groups are likely to be complex. Sexual behaviours and mixing patterns are determined by cultural background to a large extent 18 resulting in variations in the transmission patterns of STIs by ethnic group. As people more often have sexual partners within their own ethnic group, 19 existing high levels of infection are likely to be maintained. 18 However, there are known racial inequalities in socioeconomic status and in the access to, and use of, healthcare services, 18 20 with ethnic minorities being less likely to have access to good . ‡Multiple site infections were categorised as follows: "rectal" includes concurrent genital, throat, and "other" infections, "genital" includes concurrent throat and "other" infections but not rectal infections, and "throat" includes infections of the throat only. §Relates solely to drugs given to treat gonococcal infection. For multiple treatments "quinolone" includes penicillin treatment and "other drug type" includes penicillin and/or quinolone treatment.
medical care. 20 Such inequalities could facilitate infection transmission by limiting access to treatment and the eVectiveness of partner notification. None the less, certain studies have suggested that disparities in gonorrhoea prevalence by ethnic group may exist even when controlling for socioeconomic status. 8 9 The study suggests that almost one in five homo/bisexual men and about one in 16 heterosexuals presenting with gonorrhoea at GUM clinics in England in 1996 had a penicillin resistant strain. In homo/bisexual men, resistance of gonococcal strains to penicillin had also increased significantly since 1994. Unfortunately, in this study we did not collect information on type of resistance and minimum inhibitory concentration ranges. As there is likely to be considerable variability in the methodology used for measuring resistance, this somewhat limits the significance of this finding. None the less, samples submitted to the genitourinary infection reference laboratory in Bristol indicate that chromosomally mediated resistance to penicillin has been increasing since 1994, whereas penicillinase producing (plasmid) gonococcal strains have declined since 1989. 21 Penicillin is still the preferred treatment for gonorrhoea in many clinics in the United Kingdom 22 and the findings from this study warrant a review of recommended treatment of gonorrhoea at the local, if not the national, level, especially in homo/bisexual men.
Almost half the cases in 1996 had previous contact with GUM clinic services and had presumably received advice on safer sexual behaviour. It is also noteworthy that older homo/ bisexual men experienced a greater (though non-significant) rise than younger homo/ bisexual men, despite the fact that these men are most likely to have been exposed to the HIV safer sex campaigns in the 1980s. There appears to be scope for improvements in sexual health promotion in GUM clinics as a priority area for the control and prevention of gonorrhoea.
STUDY 2: CHANGE IN RISK FACTORS FOR
GONORRHOEA BETWEEN 1994 There is no evidence to suggest that the rise in cases of gonorrhoea seen at GUM clinics in England between 1994 and 1996 was driven by any single risk group. The rise was greatest in heterosexual men but there were also large rises in women and in homo/bisexual men. It is particularly important to recognise that although black Caribbeans are at higher risk than whites for the acquisition of gonorrhoea, the rate of increase of new cases in whites and black Caribbeans was similar. Recording of ethnicity improved in the Thames regions between 1994 and 1996, but not elsewhere, and this may explain the slightly higher (though nonsignificant) odds ratios associated with black Caribbeans compared with white people. Otherwise, the odds ratios calculated for study 2 are likely to be valid, as a major shift in the size of the various population subgroups between 1994 and 1996 is unlikely.
It is possible that the rise reflects an increase in incidence following sexual behaviour changes generally. A smaller increase in numbers of diagnoses among homosexual men in 1989 and 1990 was associated with changes in risk behaviour which resulted in increased HIV transmission in this group. 23 Furthermore, the significant increases in penicillin resistant gonorrhoea observed in homo/bisexual men in this study may also have increased the likelihood of treatment failure in this group. If so, it is possible that this enhanced gonorrhoea transmission in homo/bisexual men to some extent and contributed to the rise in numbers of diagnoses.
It is also possible that the rise in numbers of diagnoses could be contributed to by changes in the use of genitourinary medicine services, such as changes in health seeking behaviour resulting from sexual health promotion initiatives, or increased referrals from other healthcare settings. A change in attendance resulting from successful health promotion initiatives is perhaps unlikely in this case. Heterosexual males were the largest group in this study, and they experienced the greatest rise. Almost all infections in heterosexual males were genital, and as genital infections in males are usually symptomatic, it is reasonable to conjecture that attendance at the GUM clinic in this group was stimulated by the presence of symptoms. Also, a study of 70 000 attenders at 18 general practices in 1994 found very few were treated for gonorrhoea in this setting (unlike those who presented with genital herpes and warts, half of whom were treated in general practice without being referred to GUM clinics), such that a major shift from general practice to GUM clinics for the treatment of gonorrhoea seems implausible (CDSC, unpublished data).
In heterosexual patients, the rise among teenage females was not significantly greater than in older females but may represent a general sexual health problem in that group. 24 The increased number of patients reporting only one sexual partner may be due to increased flow of infections from high risk core groups 25 to non-core groups, resulting in a greater proportion of cases in 1996 reporting only one sexual partner. Caution with this interpretation is required, however, given the likelihood of variations in accuracy and recording of information on numbers of partners.
Homosexually acquired gonorrhoea increased particularly in the North West. Given the substantial caseload of HIV infections in the Manchester area, 17 this demonstrates the value of gonorrhoea surveillance data in indicating where there is a potential or real need for local public health action.
The study protocol was submitted to the Public Health Laboratory Service ethics committee who, after consultation with the chairman of the South Thames multicentre research ethics committee (MREC), felt that this study was essentially an outbreak investigation designed to inform immediate public health policy and, as such, did not require ethical approval.
The study would not have been possible without the commitment and hard work of medical, nursing, and administrative staV at all the participating GUM clinics. They are gratefully acknowledged. The authors also wish to thank Dr A Swan and Mrs P Rogers for additional statistical input, Mr A Brady, Dr K Fenton, Dr G Luzzi, Mr N Macdonald, Dr Macdonald-Burns, Dr A Nicoll, Mr I Simms, Dr M Tennant-Flowers, and Dr N Thin for helpful comments on an earlier draft of this paper, and Mrs P Deeks and Ms S Wellstead for administrative support.
Contributors: GH, NA, and MC designed the study; GH analysed the results with statistical guidance from NA; GH, MC, MG, MB, DF-B and AM were involved in interpretation of the results; GH and MG coordinated the study with the help of MB, DF-B, and AM; GH undertook the main writing of the paper.
The following clinicians and clinics participated in the study. 
Anglia and Oxford
West Midlands
Dr Joseph, Manor Hospital, Walsall; Dr Natin, Stratford upon Avon Hospital; Dr Murray, Burton District Hospital, Burton on Trent;
LETTERS TO THE EDITOR
Successful treatment of recalcitrant condyloma with topical cidofovir EDITOR,-Despite the high prevalence of condylomata acuminata, their treatment remains unsatisfactory for both patients and physicians. Epidemiological studies estimated the prevalence of genital warts between 1-31% with a peak occurring in young adults.
1 As a consequence, the economic burden of human papillomavirus (HPV) infection in the United States is estimated to exceed $8.5 billion per year.
2 Current treatments rely on the ablation of warts (cryotherapy, laser vaporisation, electrodissection, or trichloroacetic acid) or the interruption of cell division (podophylox, intralesional or systemic interferon, and 5-fluorouracil). Recently, imiquimod has been successfully used as a topical immune response modifier for the treatment of external anogenital warts. However, there remains a substantial number of patients who fail to respond to traditional and newer drugs. We report on such a patient with recalcitrant condylomata acuminata on the glans and shaft of the penis who was successfully treated using the novel virustatic cidofovir as a 1.5% gel.
A 48 year old man with a 2 1 ⁄2 year history of condylomata acuminata had received laser treatment, podophylox, and imiquimod. The patient's history was remarkable for diabetes mellitus. He presented with numerous, flesh coloured, flat topped papules in a circular manner on the outer preputium and the glans, whereas some lesions in the coronary sulcus had a more verruciform appearance (fig 1) . On histological analysis, the typical picture of acanthosis, papillomatosis, and numerous koilocytes was seen. Papillomavirus typing revealed HPV-43 by nested PCR using consensus primers. 4 Cidofovir was evaluated in the indicator patient at 1.5% cidofovir in a viscous gel (propylene glycol, parabene). Initially, the patient was treated on an outpatient basis with two applications of cidofovir gel per week to the respective lesions without any side eVects. Thereafter, the patient was instructed to apply the gel three times a week by self application. At week 6 the patient presented with small erosions surrounded by a marked erythema on all treated sites (fig 1) . The lesions were painful. Condylomata were still present in the coronary sulcus. At this point treatment was stopped and antiseptic treatment was given with betadine solution once daily. Seven weeks later (week 13) all lesions had completely healed (fig 1) . Neither scarring nor dysaesthesia were noted. No recurrence has occurred since. Cidofovir, 1-[(S)-3-hydroxy-2-(phosphono-methoxy)-propyl]cytosine, is a member of a new class of antiviral agents (phosphonylmethylether nucleotide analogues). 5 It shows potent in vitro activity against a broad spectrum of herpesviruses, including human cytomegalovirus (CMV), HSV-1 and HSV-2, and adenovirus. 6 Recent in vitro and in vivo studies have demonstrated activity against papillomavirus and poxvirus. 6 7 Cidofovir is a nucleotide analogue of deoxycytidine monophosphate (dCMP). Analogous to the metabolism of dCMP to dCTP, cidofovir is converted to the active cidofovir diphosphate that inhibits viral DNA polymerases. 8 The uptake of cidofovir into cells is slow, but the intracellular half life of the various metabolites is between 6 and 87 hours, thus allowing infrequent dosing. 8 Compared with the general mechanism of activation of ganciclovir, which requires phosphorylation by the virus encoded UL97 gene, cidofovir does not depend on viral infection for its phosphorylation and can therefore prime cells to an antiviral state (prophylaxis).
The metabolism of cidofovir is negligible, since the majority (>80%) is recovered unchanged in the urine. The principal systemic toxicity (nephrotoxicity) can be avoided by topical application.
This initial case report suggests that topical cidofovir may represent a valuable addition to the armamentarium of hard to treat condyloma. However, a careful evaluation of the dose and frequency of cidofovir application is warranted. Bladder carcinoma presenting to genitourinary medicine departments EDITOR,-Large numbers of patients are seen in departments of genitourinary medicine with symptoms suggesting infection or inflammation of the genitourinary tract. Although bladder neoplasms typically cause painless haematuria, in a subgroup of patients they cause other urinary symptoms that may produce diagnostic confusion. We identified five patients who were referred to the genitourinary medicine service, and who were found to have bladder carcinoma (see table  1 ). Four of the patients presented to the genitourinary medicine department at High Wycombe (5500 new attendances per annum) between 1991 and 1998; the fifth patient presented to the Oxford genitourinary medicine department (9000 new attendances per annum) in 1997. None of the patients had an occupational history that placed them at higher risk for bladder cancer. Men with bladder carcinoma typically present in later life (median age 69 years), but the condition may occur at younger ages.
U R HENGGE
1 A subgroup of patients develop frequency, urgency, and dysuria-symptoms usually associated with bladder infection.
2 Rarely, penile and perineal pain mimicking prostatitis may be a presenting feature, as in patients 3 and 4, who have been described in more detail elsewhere. Non-specific urethritis (NSU) is diagnosed commonly in genitourinary medicine clinics in men of all ages. In this series, patient 2 was referred with presumed NSU, and patient 4 had attended previously with a diagnosis of NSU, 2 years before the bladder cancer was diagnosed (at that time there were 5-10 white cells/high power field (×1000) on a urethral smear, and a chlamydia ELISA test and cultures for Neisseria gonorrhoeae were negative; no haematuria was detected). Both patients were subsequently noted to have neoplastic infiltration in the bladder neck area and prostatic urethra.
In all five cases a degree of persistent microscopic haematuria was noted at presentation; in patient 4 this was never greater than a trace on dipstick testing. Patient 1 reported intermittent painless macroscopic haematuria at presentation; he was referred by his general practitioner with suspected Figure 1 Condylomata acuminata with some lesions in the coronary sulcus having a more verruciform appearance. genitourinary infection, rather than suspected neoplasia, because of his young age (26 years).
Bladder neoplasia is especially liable to cause irritative symptoms when represented by, or associated with, carcinoma in situ of the bladder urothelium.
1 2 Urine cytology may be useful in this subgroup, and was abnormal in all three of the five patients in whom it was requested. When this process involves the prostatic urethra, symptoms mimicking prostatitis may arise. Early diagnosis of bladder neoplasia is of prognostic importance; the presence of carcinoma in situ or prostatic involvement by bladder carcinoma are poor prognostic features for which radical surgery may be required. 1 4 These cases highlight the importance of careful follow up of patients presenting with persistent irritative-type bladder symptoms, especially in an older age group, when specific tests for genitourinary infection are negative, and where microscopic haematuria is a feature. Bladder carcinoma should be considered in this subgroup; urine cytology and referral for cystourethroscopy may be indicated. Although rare in younger adult males, bladder cancer should not be ruled out in men under the age of 45 years, and our experience strengthens the case for continuing with routine urine testing in genitourinary medicine clinics. 
Atrial myxoma and HIV infection
EDITOR,-Atrial myxoma has not previously been reported in HIV infection. We describe a patient with advanced HIV disease who underwent surgery for this condition.
The patient was diagnosed with asymptomatic HIV infection in February 1987 when she was aged 50 years. Her CD4 count was 690 ×10
6 /l at this time. HIV infection was acquired through sexual intercourse with a bisexual male partner. In December 1990 the CD4 lymphocyte count had fallen to 190 ×10 6 /l and zidovudine monotherapy was started. This was continued until 1996 when she was prescribed a combination regimen. Co-trimoxazole was given for Pneumocystis carinii prophylaxis, but the patient deferred starting this until December 1992.
In February 1992 the patient was admitted to another hospital with an acute myocardial infarction which was successfully thrombolysed. Fasting lipids were within the normal range. There were no cardiac risk factors apart from smoking.
In September 1995 the patient experienced a syncopal episode. An echocardiogram revealed a mass in the left atrium consistent with a left atrial myxoma. A coronary angiogram showed normal coronary arteries. Surgical resection of the myxoma was recommended.
In December 1995 the patient's CD4 count was 64 ×10 6 /l, but apart from oral candidiasis there had been no HIV related problems since diagnosis. Two leading UK HIV physicians were asked if they considered surgery to be advisable. They estimated the patient's likely survival from HIV disease to be 1-4 years. The risks of major heart surgery had to be balanced against the likelihood of recurrent symptoms from the myxoma in the next 1-4 years. The patient and her physician agreed to proceed with surgery.
On 4 December 1995 the patient underwent surgical resection of a pedunculated left atrial mass. Histological examination confirmed a benign atrial myxoma. The procedure was uncomplicated and she was discharged from hospital 4 days later. Annual cardiac review including an echocardiogram has shown no evidence of recurrence up to the present time. She remains free from cardiovascular symptoms. Her HIV disease is managed with combination therapy that consists of stavudine, lamivudine, and efavirenz. Current CD4 count is 564 ×10 6 /l and viral load less than 50 copies/ml (Chiron bDNA v3.0) Atrial myxoma is a rare tumour that is considered to be benign although recurrence and metastases have been described. 1 The myocardial infarction suVered by our patient may have been an embolic manifestation of the myxoma, and the normal serum lipids and normal coronary angiogram almost 4 years later would support this.
In 1995 expert opinion provided a very guarded prognosis for someone with a CD4 count of 60 ×10 6 /l who had been exposed to a single antiretroviral agent, zidovudine. Today there would be less debate over the merits of such a surgical procedure in this scenario, and this case demonstrates the excellent outcome that can be achieved with major surgery despite profound immunosuppression. The proved benefits of HAART (highly active antiretroviral therapy) have made it unacceptable to deny major surgical interventions to individuals with HIV. 
Accepted for publication 25 February 2000
The association between receptive cunnilingus and bacterial vaginosis EDITOR,-We are puzzled by the surprisingly little, if any, serious work done to explain the epidemiological enigma of high prevalence of bacterial vaginosis (BV) in lesbians, 1 and the oft observed, but as yet unconfirmed association between BV and receptive cunnilingus in women in general.
In a detailed study of 17 consecutive lesbians attending the department of genitourinary medicine at the Royal Sussex County Hospital in Brighton, bacterial vaginosis was found in six women (35%). Of nine lesbians who practised receptive cunnilingus in the previous 4 weeks, six (67%) had BV. By contrast, no BV was present in all eight women who did not practise oral sex (table 1) .
In a parallel prospective study of 256 consecutive heterosexual female patients attending the same department, 55 (21%) were diagnosed as having BV. Of 111 women who practised receptive cunnilingus in the previous 4 weeks, 41 (37%) had BV. Of 145 women who did not have oral sex, only 14 (10%) had BV (table 1). In both groups there was strong association between BV and receptive cunnilingus (p<0.001).
The evidence associating bacterial vaginosis with oral sex is too strong to be ignored and repeatedly dismissed. The mouth is full of Gram positive and Gram negative organisms including Bacteroides oralis and, albeit in much smaller quantities, lactobacilli. These organisms are part of normal flora in the mouth, but are they normal to the vagina? Might the tiny amount of lactobacilli be enough to act as a phage which destroys the Is partner notification in the public interest?
EDITOR,-This ethical debate 1 calls for comment.
Why did the clinicians only suspect AIDS? Surely at the second attendance the diagnosis was clinically obvious. As well as continuing treatment of candidiasis and starting prophylaxis of Pneumocystis carinii pneumonia, was not treatment for AIDS indicated? For fear of court proceedings a specimen of blood untested or surplus to routine haematological tests could have been stored to confirm, if necessary, the clinical diagnosis. A perspicacious defence lawyer could make much of this in terms of doctor thoroughness, cautiousness, and thoughtfulness-on behalf of his client.
In terms of contact tracing the word "disclosure" occurs repeatedly. Surely the first thing an index case is told when his/her cooperation is sought is that under no circumstances will their name be divulged. The contacts, when attending, will be refused any information regarding who has named them and immediately assured that the same confidentiality will be maintained if their cooperation is called for in the contact tracing process.
Only when it becomes widely known in a clinic that such confidentiality is thoroughly pursued will counterproductive fears be eliminated. With understanding and cooperation it can be done. 
Sexual partner reduction and HIV infection
EDITOR,-We recently conducted a national urban random sample survey of 1400 men of sexually active age in the Dominican Republic to measure possible change in sexual behaviour. This sexual behaviour change (SBC) survey was prompted by results from the 1996 demographic and health survey, which found that 84.8% of a national random sample of Dominican men claimed that they had changed their behaviour in some way because of their fear of, or concern about, AIDS. The proportion of respondents reporting behaviour change such as becoming monogamous or reducing their number of sexual partners was about triple the proportion reporting condom adoption. In our SBC survey, 79% of respondents claimed to have changed behaviour because of concern about AIDS. A majority (52.2%) said they had become monogamous or reduced their number of sexual partners. This was followed by condom adoption (14.6%), only having sexual relations with a person they know (13.9%); avoiding relations with "prostitutes" (9.0%); or becoming abstinent (1.6%). A small proportion (2.8%) had not yet begun to have sexual relations. As with the Dominican DHS findings, we see that most answers are classifiable as behaviour change, as distinct from condom adoption. This follows a pattern found in recent studies in countries such as Uganda and Zambia. A recent review of findings from behavioural change surveys in 16 countries in Africa, Latin America, and the Caribbean shows that partner reduction is more often reported than condom adoption.
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If sizeable numbers of men reduce their number of sexual partners, can this have significant impact on HIV infection rates? Urban HIV seroprevalence among the general or low risk Dominican population seems to have stabilised at the 1.9-2.0% level since 1995, according to the US Census Bureau. Recent studies that have modelled the impact of diVerent interventions on HIV infection rates in east Africa suggest that reduction in number of partners can have a great impact on averting HIV infections, in fact greater than either condom use or treatment of STDs. 2 3 Of course, impact of partner reduction on HIV infection rates would be especially strong where there is relatively high HIV seroprevalence among potential partners. In view of these modelling studies as well as population based surveys such as the two cited from the Dominican Republic, perhaps there ought to be greater equity in resource allocation between HIV/AIDS prevention programmes promoting behaviour changesuch as monogamy/fidelity or at least reduction of number and frequency of change of sex partners-and far more familiar programmes that promote and provide condoms. EDWARD Features of AIDS and AIDS defining diseases during the highly active antiretroviral therapy (HAART) era, compared with the pre-HAART period: a case-control study EDITOR,-To assess the features of AIDS defining illnesses during the HAART era versus those observed before the introduction of HAART, the characteristics of 72 consecutive patients, diagnosed in 1997-9, were compared with those of 144 subjects randomly selected from the 436 patients diagnosed from 1985 to 1995, in a case-control study. An impressive drop in AIDS diagnosis was seen shortly after the introduction of HAART, with only 38, 21, and 13 cases per ∼1000 patient years observed in 1997, 1998, and 1999 respectively, versus a mean frequency >60 cases per ∼1000 patient years, demonstrated during 1991-5. A tendency towards an increased incidence of female sex was shown in 1997-9 compared with 1985-95 (33.3% versus 27.1%), together with a rise of mean CD4+ lymphocyte count (86.8 (SD 99.4) versus 72.1 (93.7) cells ×10 6 /l), while an increase in the mean patient age was highly significant (39.8 (8.3) versus 34.6 (7.7) years; p<0.0001). When considering the exposure to HIV infection, drug abuse became significantly less important in the HAART era (p<0.05), while heterosexual transmission was notably increased (34.7% versus 13.2% of cases; p<0.0003). The distribution of AIDS defining disorders during the HAART era showed an tendency to a reduction in cytomegalovirosis, cryptococcosis, mycobacteriosis, cryptosporidiosis, and HIV encephalopathy, while a relative increase in pneumocystosis, oesophageal candidiasis, wasting syndrome, tuberculosis, and non-Hodgkin's lymphoma was found; neurotoxoplasmosis and Kaposi's sarcoma were stable (table 1) . However, while pneumocystosis, Candida oesophagitis, neurotoxoplasmosis, and Kaposi's sarcoma represented the four most frequent AIDS related events in both study periods, cytomegalovirosis, HIV encephalopathy, cryptococcosis, and mycobacteriosis (which ranked fifth to eighth in Although a sharp decline in the incidence of multiple AIDS defining events was demonstrated since the introduction of HAART, the distribution of primary AIDS associated diseases showed limited modifications. 1-3 An increased incidence of women, a higher patient age, a greater role for heterosexual transmission compared with injecting drug addiction, and a rise in CD4+ count were disclosed by us in the HAART era compared with the pre-HAART period. Appreciable modifications of the spectrum of AIDS associated illnesses were also observed during the HAART era (a drop of cytomegalovirosis, cryptococcosis, mycobacteriosis, cryptosporidiosis, and HIV encephalopathy, with a parallel increase in pneumocystosis, oesophageal candidiasis, wasting syndrome, tuberculosis, and non-Hodgkin's lymphoma), together with a considerable trend towards an increased mean CD4+ count at diagnosis, as previously noted. 2 5 Disorders which are directly or indirectly associated with HIV damage itself, AIDS related neoplasms, and opportunistic diseases occurring with a less profound immunodeficiency, show a substantially stable or even increasing incidence among newly diagnosed cases of AIDS. How do you begin to address the sexual health needs of commercial sex workers (CSWs)? Here you will find (most of) the answers. This immensely practical book is essential for those setting up an outreach service, or simply wishing to know more about commercial sex work. It is the outcome of a series of projects and workshops, written by workers providing services to CSWs throughout Europe, and draws from the lessons learnt by these pioneering workers and clients. It is written with great clarity and frankness. The A4 layout is bold, imaginative, and attractive, with illustrations of promotional literature. Its European inclusiveness means that sadly it cannot be specific regarding, for example, the law as it applies to commercial sex. It does, however, give the broad framework with which providers must acquaint themselves wherever they work. It takes us through the steps; sources of funding, the scope of the service, useful contacts, where to make contact with CSWs, and so on. Importantly, in the current climate there are sections on evaluation and monitoring of the service, the legal and political context of the work, and dealing with the media. It stresses the heterogeneous nature of commercial sex workers whether male, female, or transsex, and the spectrum of commercial sex venues. Peer educator programmes are covered in some detail.
There are fascinating pieces of practical advice-for example, cooperate with police, but don't be identified too closely with law enforcement. Advising police of your outreach vehicle's registration number may prevent you being stopped for kerb crawling! You can set up a flawless screening service and find only a few CSWs attend. The book reminds us middle class, health aware professionals that, for many, sexual health is not a priority. We are perplexed when faced with "indiVerence, hostility and self destructive behaviour"; that her next fix, a roof over her head, or the desire to have a baby might be more important to the CSW than the nebulous risk of HIV. Address some of these needs and you have the carrot to attract attention to and confidence in your service. The spin oV is that clients can then benefit from STD screening and safer sex advice. Simply providing toilets and somewhere safe to have a cup of tea may be enough for some.
I would have liked to see a further reading list, but this book fulfils its remit excellently. The 13 000 bodies providing CAMHS spend £100 billion (sic) of public money annually in England and Wales. The Commission's team of seven have met with external advisers with a view to shaping of the audit, its comments, and guidance. The aim is to achieve economy with eYciency and eVectiveness. The report is in five chapters and five helpful appendices. It lists 71 references and has an index.
Under the heading "The changing context" it is revealed that one in five children and adolescents (alas, not defined for females and males) suVer from a wide range of mental health problems of variable degrees of severity from social ineptitude through psychological to severe psychiatric disorder. Strong links are noted with juvenile crime, alcohol and drug abuse, eating disorders, and of course self harm.
The key components of the CAMHS are viewed as four "tiers": (a) Those providing primary intervention, eg, GPs, health visitors, residential social workers, juvenile justice workers, school nurses, and teachers. (b) Professional providers of services, eg, clinical and educational psychologists, paediatricians, child psychiatric nurses in the community, and child psychiatrists. (c) High grade specialist services for severe, complex and persistent disorders, eg, child psychiatrists, community psychiatric nurses, psychotherapists, occupational therapists and art, music, and drama therapists. (d) Consists of hospital services especially unnamed "highly specialised outpatient teams". This clearly applies to accident and emergency departments, obstetric and gynaecology departments, and genitourinary medicine departments. These deal very adequately with self poisoning episodes, premarital abortions, and sexually acquired infection, but fail to see the underlying behaviour as but one manifestation of an ongoing complex of medicosocial pathology. Clearly, services for the care of our adolescents, unlike paediatrics and geriatrics, are seriously fractionated.
What follows should help the holistically minded hospital doctor to increase his awareness and skills and so make more regular and early use of referral routes and emergency cover arrangements provided by developing CAMHS.
It is clear that in many areas there is an urgent need to plan how best to meet unmet needs, including appropriate monitoring. The final chapter of this book purports to show how, with national support, highly active local coordination can establish and advance improvements. Recommendations are provided. There are opportunities for masterly leadership.
As the first specialty to be nationalised in the United Kingdom, genitourinary medicine has come a long way from the days of "pox doctoring" in "clap clinics". Has the time come for it to give a lead in the development of more appropriate and comprehensive services for adolescents?
For the long sighted and adventurous GU physician this book suggests how to begin. Sexually transmitted diseases (STDs) now rank among the top ten diseases for which adults in developing countries seek health care. The economic burden of STDs on both developed and developing countries is enormous. Infection with conventional STDs is a risk factor for transmission of infection with HIV, and therefore for the development and spread of the AIDS It is imperative that laboratory services are available to guide the clinician to the correct diagnosis and treatment of these conditions, and to give an accurate epidemiological picture of their prevalence in a particular community in order to target relevant populations and ensure optimal and economic use of available resources. Yet, the availability of both funds and technology varies widely between diVerent settings.
R S MORTON
This manual sets out to give comprehensive guidance on tests available and applicable to the level of expertise and funding available.
Nine chapters cover the major STDs, encompassing bacterial and viral infections, and under the umbrella of vaginitis in adults; trichomoniasis, candidiasis, and bacterial vaginosis. Each chapter begins with a brief description of the microbiology of the infective agent and the clinical spectrum of disease. The detail given is not consistent, being comprehensive for chancroid and granuloma inguinale, and surprisingly brief for HIV and chlamydia by way of contrast. Then follows a description of collection and transport requirements, and of techniques for diagnosis. The emphasis is on tests that are possible in a reasonably well equipped laboratory, but not one capable of reference facilities. Tests that are suitable for use in the field are highlighted. An evaluation of sensitivity and specificity is also given. Other tests available in central or reference laboratories are mentioned in brief, usually with supporting references.
Two annexes cover media, reagents and stains, and details of equipment required to diagnose each condition. A third annex is an interesting table of which tests should be available at "peripheral," "intermediate," and "central" laboratories.
Overall, this manual is to be welcomed as an educational and reference source for medical microbiologists, technologists, and clinicians. However, I would recommend that the authors "road test" the manual to discover omissions in technical detail that would prevent the sole use of the manual in the field.
IndiVerent colour reproduction detracts from the quality of the text-for example, blue reactions appearing as red in the figure.
For the next edition, a chapter on basic microscopical techniques and another on the general principles and interpretation of laboratory tests would provide useful introductions to an otherwise excellent publication.
GEOFFREY L RIDGWAY
Department of Clinical Microbiology, UCH Accident and Emergency Building, London WC1E 6DB
CD-ROM REVIEWS Each tutorial is self contained (which does lead to some duplication) and has self assessment questions-usually with click and drag matching of statements or true/false boxes. The information itself is well illustrated and contains animations and a video clip, together with further information/annotations in pop up boxes. At the end of each section there is a set of summary points, a reading list, and further activities such as internet sites.
There is a searchable picture index which allows you to search, view, and save sets of images for reference and lectures (although copyright does apply), and a glossary of terms.
Overall this is an excellent CD Rom providing good information, presented in an attractive and usable way, with a wealth of illustrations. I would strongly recommend it. This is an interesting CD Rom which, gives a very personal guide to issues surrounding HIV-covering the experience of the patient, carer and healthcare professionals.
Four main sections cover the following areas: Living with HIV, Is HIV diVerent? Loss, grieving and bereavement, Supporting people aVected by HIV.
These areas are illustrated by short video clips and backed up by further information. Basic information is given about HIV treatment, the impact of diagnosis and of ill health, and other related topics. Unfortunately the information about drug treatment is already outdated and there is no search facility.
The strength of this CD Rom is the view it gives of the emotional responses to HIV and the strategies for coping with the infection from the viewpoint of those involved. The academic content is limited but it is worth a look for the patient perspectives. 
SARAH EDWARDS
